Keyword

bimagrumab

Description: An investigational monoclonal antibody that blocks activin type II receptors and is studied as a treatment for muscle loss and metabolic conditions.
Wikidata ID: wiki/Q15708291
OpenAlex ID: keywords/bimagrumab
2024 · Eka Melson, Uzma Ashraf, et al. · International Journal of Obesity · 409
2013 · Estelle Lach-Trifilieff, Giulia C. Minetti, et al. · Molecular and Cellular Biology · 330
2017 · Daniel Rooks, Jens Praestgaard, et al. · Journal of the American Geriatrics Society · 273
2014 · Anthony A. Amato, Kumaraswamy Sivakumar, et al. · Neurology · 217
2015 · Michaël R. Laurent, Vanessa Dubois, et al. · Molecular and Cellular Endocrinology · 163
2017 · Frederic Morvan, Jean-Michel Rondeau, et al. · Proceedings of the National Academy of Sciences · 157
2023 · Clifford J. Bailey, Peter R. Flatt, et al. · Peptides · 127
2018 · Michael I. Polkey, Jens Praestgaard, et al. · American Journal of Respiratory and Critical Care Medicine · 122
2026 · Steven B. Heymsfield, Louis J. Aronne, et al. · Nature Medicine · 102
2017 · Daniel S. Rooks, Didier Laurent, et al. · Journal of Cachexia Sarcopenia and Muscle · 101
2017 · Tania Garito, Ronenn Roubenoff, et al. · Diabetes Obesity and Metabolism · 90
2025 · Xiangliang Liu, Xinqiao Chen, et al. · Clinical Nutrition · 78
2016 · Alessio Molfino, Maria Ida Amabile, et al. · Expert Opinion on Biological Therapy · 58
2024 · Mehmet Kanbay, Dimitrie Siriopol, et al. · Aging Clinical and Experimental Research · 57
2020 · Daniel Rooks, Olivier Petricoul, et al. · Journal of Cachexia Sarcopenia and Muscle · 57
2025 · Donna H. Ryan · Reviews in Endocrine and Metabolic Disorders · 51
Works count: 143
Citation count: 4,311
Year
Topic
Type